Publicaciones en las que colabora con María del Carmen Costas Lago (11)

2022

  1. Novel Pyridazin-3(2H)-one-Based Guanidine Derivatives as Potential DNA Minor Groove Binders with Anticancer Activity

    ACS Medicinal Chemistry Letters, Vol. 13, Núm. 3, pp. 463-469

2021

  1. Pyridazinones containing dithiocarbamoyl moieties as a new class of selective MAO-B inhibitors

    Bioorganic Chemistry, Vol. 115

2020

  1. Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson's disease therapy

    Bioorganic Chemistry, Vol. 104

2019

  1. Novel compounds of hybrid structure pyridazinone-coumarin as potent inhibitors of platelet aggregation

    Future medicinal chemistry, Vol. 11, Núm. 16, pp. 2051-2062

  2. Recent advances in the synthesis of phthalazin-1(2H)-one core as a relevant pharmacophore in medicinal chemistry

    European Journal of Medicinal Chemistry

2017

  1. Synthesis and structure-activity relationship study of novel 3-heteroarylcoumarins based on pyridazine scaffold as selective MAO-B inhibitors

    European Journal of Medicinal Chemistry, Vol. 139, pp. 1-11

2015

  1. New platelet aggregation inhibitors based on pyridazinone moiety

    European Journal of Medicinal Chemistry, Vol. 94, pp. 113-122

  2. Phthalazin-1(2H)-one as a remarkable scaffold in drug discovery

    European Journal of Medicinal Chemistry, Vol. 97, Núm. 1, pp. 462-482

2013

  1. 2-Benzyl-5-methoxyisoindoline-1,3-dione

    Acta Crystallographica Section E: Structure Reports Online, Vol. 69, Núm. 10

  2. 4-[(tert-Butyldiphenylsilyloxy)methyl]pyridazin-3(2H)-one

    Acta Crystallographica Section E: Structure Reports Online, Vol. 69, Núm. 12

  3. 5-[(tert-Butyldiphenylsilyloxy)methyl]pyridazin-3(2H)-one

    Acta Crystallographica Section E: Structure Reports Online, Vol. 69, Núm. 12